Polar Asset Management Partners Inc. Viridian Therapeutics, Inc.\De Transaction History
Polar Asset Management Partners Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Polar Asset Management Partners Inc. transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 163,000 shares of VRDN stock, worth $3.51 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
163,000
Previous 109,900
48.32%
Holding current value
$3.51 Million
Previous $1.43 Million
159.48%
% of portfolio
0.12%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding VRDN
# of Institutions
179Shares Held
76.8MCall Options Held
581KPut Options Held
439K-
Black Rock Inc. New York, NY4.77MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$95.2 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$83.6 Million9.15% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.75MShares$80.8 Million3.15% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.45MShares$74.2 Million12.74% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $859M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...